Advisories: limited to 12 weeks of therapy, non-formulary required for continuation of therapy beyond 12 weeks
Non-Formulary Use Criteria: 1. Restricted to 12 weeks of therapy for all formulations 2. If NFR approved, after 12 weeks, get periodic AIMS testing